Tag Archives: Dementia Prevention

WHO Guidelines on Dementia Prevention (BBC News / WHO)

Posted on May 15, 2019 by Dementia and Elderly Care News

Summary The World Health Organization (WHO) has issued guidelines on the prevention of cognitive decline and dementia. This follows earlier related guidance and consensus statements from other bodies, nationally and internationally, which recommend the adoption of healthy lifestyles for healthier … Continue reading →

Posted in Commissioning, Community Care, Depression, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Models of Dementia Care, Non-Pharmacological Treatments, Quick Insights, Standards, Universal Interest, World Health Organization (WHO) | Tagged Active and Healthy Ageing, Ageing and Dementia, Ageing Population, Alcohol and Drug Consumption, Alcohol Consumption, Alcohol Misuse, Alcohol or Tobacco Withdrawal, Alcohol Use Disorders (AUDs), Alcohol Use Disorders and Cognitive Impairment Risk, BBC Health News, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Blood Pressure, Cardiovascular Risk Factors (CVRF), Cholesterol (Dyslipidaemia), Cognitive Decline and Dementia: Risk Reduction, Cumulative Benefit of Reducing Risk Factors, Dementia and Sensory Loss, Dementia Policy, Dementia Prevention, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Diabetes Mellitus, Diet and Dementia, Dietary Factors, Eating and Drinking, Education and Awareness, Global Action Plan for Public Health Response to Dementia (WHO), Healthy Ageing, Healthy Lifestyles, Healthy Lifestyles and Public Health Programmes, Healthy Living, Hearing Loss, Hearing Loss and Cognitive Decline, Hearing Loss and Dementia, Hypertension, Later Life, Life-Course Approach to Healthy and Active Ageing, Lifestyle Risk Factors, Lifestyle Weight Management, Midlife Hypertension, Modifiable Risk Factors, Mortality Risk Factors, Neurological Disorders, Obesity, Obesity Risk, Obesity Time-Bomb, Participation in Social Activities, Physical Activity, Preventing Type 2 Diabetes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prevention Better Than Cure, Prevention of Dementia, Prevention Programmes, Preventive Care, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Public Awareness, Public Health, Public Health Interventions, Reducing the Incidence of Dementia, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Risk Factors and Preventive Interventions for Dementia, Risk Reduction of Cognitive Decline and Dementia, Sensory Loss, Smoked Tobacco, Social Activities, Staying Healthy for Longer, Successful Ageing, Supporting Healthy Lifestyles, Tobacco Cessation, Type 2 Diabetes, Type 2 Diabetes: Prevention, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, Weight Management, Weight Management Programs, WHO Global Dementia Observatory (GDO), WHO Guidelines, WHO Guidelines on Dementia Prevention, WHO’s Global Dementia Observatory, World Health Organization (Geneva), World Health Organization (WHO) Guidelines on Dementia Prevention | Leave a comment

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Posted on March 2, 2019 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018 | Leave a comment

Global Burden of Disease (Alzheimer’s Disease and Other Dementias, 1990-2016) Study: 2018 Update (Lancet Neurology)

Posted on December 15, 2018 by Dementia and Elderly Care News

Summary An update to the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study of 2016 has been published. The number of people living with dementia globally appears to have more than doubled between 1990 to 2016. “In the … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Quick Insights, Statistics, Systematic Reviews, Universal Interest | Tagged Age Standardised Death Rates, Age-Standardised Years of Life Lost (SYLL), Ageing Population, All-Cause Mortality, All-Cause Mortality and Cause-Specific Mortality for 249 Causes of Death (1980–2015), Alzheimer’s Disease: Prevalence, Amenable Mortality, Behavioural Risk Factors, Bill and Melinda Gates Foundation, DALYs, Dementia and Mortality, Dementia Prevention, Dementia Risk Factors, Diet High in Sugar-Sweetened Beverages, Disability Adjusted Life Years (DALY), Disease Burden, DisMod-MR 2.1 Model, Epidemiology, Epidemiology and Statistics, GBD 2016 Alzheimer’s Disease and Other Dementia Collaborators, Global Burden of Diseases Injuries and Risk Factors (GBD) Study, High Body-Mass Index (BMI), High Fasting Plasma Glucose, Lancet Neurology, Life Expectancy, Lifestyle Risk Factors, Modeling Causes of Death: Integrated Approach Using CODEm, Modifiable Risk Factors, Mortality, Prevalence, Prevalence of Cancer, Prevalence of Dementia, Prevention, Prevention Agenda, Prevention Programmes, Public Health, Risk Factors, Smoking, Social Epidemiology, Sugar- and Artificially Sweetened Beverages, Years Lost Due to Disability (YLD), Years of Life Lost (YLLs), YLDs | Leave a comment

Risk of Dementia in Patients Using Antidepressants? (Behavioural Neurology / BBC News)

Posted on October 23, 2018 by Dementia and Elderly Care News

Summary Evidence indicating that use of antidepressants is associated significantly with an increased risk of developing dementia: Full Text Link Reference Wang, YC. Tai, PA. [and] Poly, TN. [et al] (2018). Increased risk of dementia in patients with antidepressants: a … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Pharmacological Treatments, Quick Insights, Systematic Reviews, Universal Interest | Tagged Anti-Depressant Drugs, Antidepressant Prescriptions in England, Antidepressants, Antidepressants and Risk of Dementia, BBC Health News, Behavioural Neurology (Journal), Buddhist Tzu Chi University (Hualien Taiwan), Cognitive Impairment (Potential Risk and Protective Factors), Cognitive Impairment (Potential Risk Factors), College of Medical Science and Technology: Taipei Medical University, Dementia Prevention, Dementia Risk Factors, Dementia Risk Reduction and Prevention, Department of Dermatology: Wan Fang Hospital, Department of Emergency: Min-Sheng General Hospital, Department of Surgery: Buddhist Tzu Chi University, Epidemiology, Epidemiology and Statistics, Graduate Institute of Biomedical Informatics: Taipei Medical University, Min-Sheng General Hospital (Taoyuan City Taiwan), Modifiable Risk Factors, Mono-Amine Oxidase Inhibitors (MAOIs), Monoamine-Oxidase B Inhibitors, Neurocognitive Disorders, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Overlapping Risk Factors, Prevention, Prevention Agenda, Prevention of Dementia, Primary and Secondary Prevention of Dementia, Risk Factors, School of Medicine: Buddhist Tzu Chi University, Selective Serotonin Reuptake Inhibitors (SSRIs), SSRIs: Selective Serotonin Reuptake Inhibitors, Systematic Reviews and Meta-Analyses, Taipei Medical University, Taiwan, TMU Research Center of Cancer Translational Medicine (Taipei Taiwan), Tricyclic Antidepressants, Tricyclics (TCAs), Wan Fang Hospital (Taipei Taiwan) | Leave a comment

Summary of Recent Progress in Alzheimer’s Disease Prevention Trials (CTAD / JPAD)

Posted on October 1, 2018 by Dementia and Elderly Care News

Summary The following article summarises a round-up of present understanding and developments reflected in current and planned prevention trials, as discussed at a EU / US / Clinical Trials in Alzheimer’s Disease (CTAD) Task Force meeting, as of December 2016-7. … Continue reading →

Nutritional and Dietary Factors Likely to Influence Future Risk of Cognitive Impairment and Dementia (Lancet Neurology / BBC News / BNF)

Posted on September 22, 2018 by Dementia and Elderly Care News

Summary A Lancet Neurology review covers what is currently known about the various associations between diet and nutrition and the risk of developing cognitive decline or dementia. Unfortunately, access to the full-text will not be available freely for most readers, … Continue reading →

Posted in BBC News, In the News, Universal Interest | Tagged Alcohol and Dementia, Alcohol Consumption, Alpha-Tocopherol (Vitamin E), Antioxidant Supplements, Antioxidants, B Vitamins, BBC Health News, Beta-Carotene, British Nutrition Foundation (BNF), British Nutrition Foundation: Quality Calorie (QC) Concept, British Nutrition Foundation’s Quality Calorie Concept, Cardiometabolic Risk Factors, Cardiovascular Risk Factors (CVRF), Carotenoids, Cobalamin, Coffee Consumption, Cognitive Decline, Cognitive Impairment, Cognitive Impairment (Potential Risk and Protective Factors), Cognitive Impairment (Potential Risk Factors), Dairy Consumption, Dementia Prevention, DHA: Docosahexaenoic Acid, Diet and Cognitive Decline, Diet and Dementia, Diet and Nutrition, Dietary Assessment, Dietary Fat Intake, Dietary Patterns, Dietary Risk Factors, Docosahexaenoic Acid, Docosahexaenoic Acid (DHA), Epidemiology, Epidemiology and Statistics, Fat Intake, Fish Intake, Flavonoids, Folate, Folate (Folic Acid or Vitamin B9), Folic Acid, Homocysteine, Increased Fat Intake, Lancet Neurology, Lifestyle Risk Factors, Mediterranean Diet, Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND Diets), Mild Cognitive Impairment (MCI), Milk and Dairy Consumption, MIND Diet, Moderate Alcohol Consumption, Modifiable Risk Factors, Multimodal Dementia Prevention, Neuroprotection, Neuroprotection Research, Neuroprotective Agents, Neuroprotective Dietary Patterns Associated With Better Cognitive Performance, Neuroprotective Diets, Niacin, Nordic Prudent Diet Reduces Risk of Cognitive Decline, Nordic Prudent Dietary Pattern (NPDP), Nutrients and Bioactives in Green Leafy Vegetables: Alpha Tocopherol (Vitamin E), Nutrients and Bioactives in Green Leafy Vegetables: Folate (Folic Acid or Vitamin B9), Nutritional and Metabolic Disorders, Omega-3 Fatty Acids, Omega-3 PUFA Supplementation (Dietary), Oxidative Stress, Polyphenols, Polyunsaturated Fats, Polyunsaturated Fatty Acids, Polyunsaturated Fatty Acids (PUFA), Prevention Agenda, Prevention Approaches, Prevention of Vascular Dementia, Protective Factors for Cognitive Decline and Dementia, Quality Calorie (BNF), Quality Calorie (QC) Concept, Quality Calories, Resveratrol, Risk and Protective Factors for Cognitive Decline and Dementia, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Saturated Fatty Acids, Seafood, Slowing of Cognitive Decline, Tea, Tinned Food, Trans Fatty Acids, Vascular Risk Factors, Vitamin A, Vitamin A Deficiency, Vitamin A Supplementation, Vitamin B12, Vitamin B6, Vitamin C, Vitamin D Deficiency, Vitamin D Supplementation, Vitamin D Supplements, Vitamin E, Vitamin E Supplementation | Leave a comment

Alcohol Consumption in Moderation Perhaps Not Too Harmful: Some Neuroprotective Benefits? (BBC News / BMJ / NHS Choices / Heart)

Posted on August 3, 2018 by Dementia and Elderly Care News

Summary New evidence suggests that moderate levels of alcohol consumption (drinking between 7 – 14 units of alcohol per week) results in a lower level of risk for developing dementia, when compared to the dementia risk for either heavy drinkers … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Statistics, UK, Universal Interest | Tagged A Little Bit of What You Fancy Does You Good (Public Health Controversies), Affiliated Luohu Hospital (Shenzhen China), Ageing Population, Alcohol, Alcohol and Dementia, Alcohol Consumption, Alcohol-Related Brain Damage, Alcohol-Related Harm, Association Between Alcohol Consumption Per Week and Risk of Dementia by Age, Bazian, BBC Health News, BBC Reality Check: Alcohol Consumption, Behind the Headlines, BMJ, BMJ Publishing Group Ltd, British Heart Foundation, British Medical Journal (BMJ), Cardiometabolic Risk Factors, Cardiovascular Disease, Cardiovascular Risk, Cardiovascular Risk Factors, Cardiovascular Risk Factors (CVRF), Centre for Research in Epidemiology and Population Health: Université Paris-Saclay, China, Chocolate Consumption, Chocolate Consumption and Incident CVD, Chocolate Consumption and Risk of Cardiovascular Disease, Civil Service Departments in London: Whitehall II Study, Cognitive Impairment (Potential Risk and Protective Factors), Cognitive Impairment (Potential Risk Factors), Cognitive Neurology Center: Lariboisière-Fernand Widal Hospital, College of Public Health: Zhengzhou University, Counter-Intuitive Evidence on Moderate Alcohol and Chocolate Consumption, Critical Appraisals, CVD: Cardiovascular Disease, Dementia Prevention, Dementia Risk Factors, Dementia Risk Reduction and Prevention, Department of Epidemiology and Health Statistics: Zhengzhou University, Department of Epidemiology and Public Health (University College London), Department of Preventive Medicine: Shenzhen University Health Science Center, Department of Psychiatry and Autism Resources Centre: University Research and Hospital Center (CHRU) of Montpellier, France, Hôpital Paul Brousse (France), Healthy Ageing, Lariboisière-Fernand Widal Hospital, Lifestyle Risk Factors, Medical Research Council (MRC), Midlife Alcohol Consumption, Moderate Alcohol Consumption, Moderate Chocolate Consumption, Moderate Drinking, Modifiable Risk Factors, Neuroprotective Diets, Neuroprotective Lifestyles, Overlapping Risk Factors, Prevention, Prevention Agenda, Public Health, Risk Factors, Shenzhen University Health Science Center, Systematic Reviews and Meta-Analyses, Université Paris Diderot, Université Paris-Saclay, University College London, University Montpellier, University Research and Hospital Center (CHRU) of Montpellier, US National Institute of Aging, US National Institute on Aging, Whitehall Cohort Study, Whitehall II Study, Zhengzhou University | Leave a comment

Tag Archives: Dementia Prevention

Risk of Dementia in Patients Using Antidepressants? (Behavioural Neurology / BBC News)

Nutritional and Dietary Factors Likely to Influence Future Risk of Cognitive Impairment and Dementia (Lancet Neurology / BBC News / BNF)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites